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Background: Oxalosis is a metabolic disorder characterized by deposition of oxalate crystals in various organs
including the kidney. Whereas primary forms result from genetic defects in oxalate metabolism, secondary forms of
oxalosis can result from excessive intestinal oxalate absorption or increased endogenous production, e.g. after
intoxication with ethylene glycol.
Case presentation: Here, we describe a case of acute crystal-induced renal failure associated with excessive
ingestion of rhubarb in a type 1 diabetic with previously normal excretory renal function. Renal biopsy revealed
mild mesangial sclerosis, but prominent tubular deposition of oxalate crystals in the kidney. Oxalate serum levels
were increased.
Conclusion: Acute secondary oxalate nephropathy due to excessive dietary intake of oxalate may lead to acute
renal failure in patients with preexisting renal disease like mild diabetic nephropathy. Attention should be payed to
special food behaviors when reasons for acute renal failure are explored.
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Oxalosis is a metabolic disorder characterized by de-
position of oxalate crystals in various organs including
the kidney. Primary and secondary forms of oxalosis
can be distinguished. Primary oxalosis or hyperoxaluria
(PH) is caused by genetic disorders. The most common
genetic defects comprise mutations in the genes encoding
for alanin-glyoxylate-aminotransferase (AGXT) resulting
in PH type 1, and glyoxylate-reductase/hydroxypyruvat-
reductase (GRHPR) causing PH type 2. Recently, a third
gene defect leading to a deficiency of 4-hydroxy-2-
oxoglutarate aldolase (HOGA1) has been identified as the
cause of PH type 3 [1]. Typically, disease manifestations
occur in childhood or adolescence. Prognosis is poor,
since approximately 50% of diagnosed patients progress
to end-stage renal disease (ESRD). Treatment of primary
forms comprises hemodialysis or peritoneal dialysis for* Correspondence: Marc.Albersmeyer@med.uni-muenchen.de
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distribution, and reproduction in any mediumrenal failure, yet cannot prevent progression of disease
as elimination of oxalate by dialysis is insufficient.
Therefore, combined kidney/liver transplantation is the
treatment of choice [2].
Secondary forms of hyperoxaluria may result from
increased intestinal oxalate absorption (termed enteric
hyperoxaluria), endogenous production, or increased diet-
ary intake. Enteric hyperoxaluria accounts for approxi-
mately 5% of all cases of hyperoxaluria and is associated
with fat malabsorption due to small bowel disease or
cystic fibrosis. The suggested mechanism leading to
hyperoxaluria in these cases is a net loss of calcium via
unresorbed bile acids, which in turn is not available to
bind oxalate in the intestinal lumen. Calcium-bound
oxalate is normally excreted via the feces, whereas un-
bound oxalate can be absorbed via the colonic mucosa
[3]. Interestingly, bariatric surgery can increase oxalate
absorption in the colon and thus may be an iatrogenic
cause of hyperoxaluria [4]. Hyperoxaluria can also result
from ingestion of ethylene glycol, high doses of vitamin C
[5], or vitamin B6 deficiency [4] that result in increasedntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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causes include hyperparythyreoidism and sarcoidosis [6].
Here, we describe a case of acute renal failure after ex-
cessive ingestion of rhubarb in a type 1 diabetic with
previously normal excretory renal function, with tubular
deposition of oxalate crystals evident on renal biopsy.
Case presentation
The 52 year-old caucasian female patient suffered from
reoccurring episodes of nausea and vomiting in the pre-
ceding days. With a known history of type 1 diabetes,
the patient was admitted to clinic in a state of severe
hypoglycemia. On admission an elevated serum creatin-
ine was noted, with creatinine levels initially being
3.6 mg/dl and an estimated glomerular filtration rate
(eGFR, according to the modified of diet in renal disease
(MDRD) equation) of 13.3 ml/min/1.73 m2. Postrenal
causes were excluded by renal ultrasound which did
not show any signs of obstructive nephropathy or intra-
renal and ureteral concrements. Since the calculated
fractional excretion of urea was 40.8% and renal func-
tion did not show improvement upon intravenous vol-
ume challenge, prerenal causes appeared unlikely and the
patient was transferred to the nephrology department for
further evaluation. The patient denied any use of non-
steroidal antirheumatic drugs (NSAR) such as diclofenac
or ibuprofen, and she had not been exposed to contrast
media recently.
The patient was diagnosed with diabetes type 1 several
years ago and has been treated with insulin on an inten-
sified conventional therapy (ICT) regimen. Previously,
renal function was normal, with creatinine values
remaining below 1.0 mg/dl, corresponding to a eGFR >
60 ml/min/1.73 m2 at routine consultations with her dia-
betologist. However, urinalysis several years ago showed
a significant microalbuminuria of 100 mg/dl as tested by
screeining dipstick analysis. Thus, chronic kidney disease
(CKD) stage one according to “Kidney disease: Improving
global outcomes” (KDIGO) had been diagnosed. The
patient’s medical history comprised a severe depression.
Currently, she described a stable psychiatric situation,
and had discontinued the pharmacological treatment
with venlafaxin several months ago. There was no history
of kidney stones both in the patient or her family. In
addition, there was no history of small bowel disorders.
Current medication of the patient included insulin and
insulin glargin, as well as ramipril, metoprolol and low-
dose aspirin. This medication has been taken for several
years.
Physical examination revealed a 52-year-old patient in
good physical condition. Blood pressure was slightly ele-
vated (145/76 mmHg), heart beat at regular rate and
rhythm. She was breathing normally and was afebrile.
There was no lymphadenopathy in the cervical, nuchal,supra- or infraclavicular regions. Skin examination was
unremarkable. Mucous membranes were moist without
signs of candidosis. Lung and heart auscultation were
unremarkable. Jugular veins were slightly distended at
2 cm on both sides; however, no significant periph-
eral edema was present. Abdominal examination was
unremarkable. The patient showed signs of lower leg
varicosis bilaterally. Vascular status showed a lack of
palpable pulses downstream of the popliteal artery on
the left side, no foot ulcerations were noted. Neurological
examination was unremarkable.
Laboratory testing showed a mild hyperchromic
anemia (Hb 10.5 g/dl). Serum creatinine was 3.6 mg/dl,
corresponding to an eGFR of 13.3 ml/min/1.73 m2 using
the MDRD-equation (Table 1). The patient presented
with hyperkalemia (5.9 mmol/l), hyperphosphatemia of
5.1 mg/dl (reference range 2.5-4.8 mg/dl) and a mild
hypercalcemia as revealed by a protein-corrected calcium
value of 2.55 mmol/l (reference range 2.15-2.50 mmol/l).
Thyroid and liver function tests were unremarkable.
Urine examination revealed a proteinuria of 3.7 g protein
per g creatinine, being mostly albumin (2.6 g/g creatinine).
Intact parathyroid hormone was increased to 103 pg/ml
(reference range 15–65 pg/ml). Urine microscopy showed
no evidence for acanthocytes, erythrocyte casts, tubular
casts or crystals. Autoantibody testing revealed a slightly
elevated ANA-titer of 1:120, with normal values for
complement. ANCA-antibodies and anti-GBM-antibodies
were not detected.
A kidney biopsy was performed and showed mild dia-
betic mesangial sclerosis. Moreover, multiple birefringent
crystallinous casts were found within the tubular lumen
(Figure 1). No changes typical for ischemic renal failure
were noted. Upon further questioning, the patient
reported an increased ingestion of approximately 500 mg
of rhubarb (fresh weight) per day in the last 4 weeks.
Consumption of vitamin C or ethylene glycol was denied.
Additional laboratory tests revealed elevated serum oxal-
ate levels (13.75 μmol/l, reference range <6.5 μmol/l),
whereas urinary excretion of oxalate, glycolate, citrate
and calcium were normal (Table 2). Serum levels of folic
acid, as well as vitamin B12 were within the normal range.
The patient underwent an ophthalmological examination
which showed no evidence for corneal of retinal oxalate
deposition.
The history of high oxalate intake, the elevated serum
oxalate levels, and the histological detection of intra-
tubular birefringent crystals lead to the diagnosis of
secondary oxalosis, being the most likely cause for the
acute decline in the patient`s renal function. Since no
established causative therapy for secondary oxalosis is
available, intravenous fluid replacement was started,
leading to an initial stabilization of renal function
with an eGFR at 15 ml/min/1.73 m2. However, upon





Leukocytes (G/l) 4.0−11.0 7.9
Erythrocytes (T/) 4.20−5.10 3.1
Hemoglobin (g/dl) 12.0−16.0 10.5
Hematocrit (%) 36.0−46.00 30.4
Mean corpuscular volume (fl) 78.0−98.0 98




Platelet count (G/l) 150−400 351
Serumchemistry
Sodium (mmol/l) 135−145 138
Potassium (mmol/l) 3.5−5.0 5.9
Glucose (mg/dl) 60−100 191
Urea nitrogen (mg/dl) 7−23 55
Creatinine (mg/dl) 0.5−1.0 3.6
Estimated glomerular filtration rate
(MDRD) (ml/min/1.73 m2)
≥60.0 13.3
Calcium (mg/dl) 2.15−2.50 2.53
Calcium (protein-corrected) (mmol/l) 2.15−2.50 2.55
Phosphorus (mg/dl) 2.5−4.8 5.1
C−reactive protein (mg/dl) <0.50 0.18
Total protein (g/dl) 6.0−8.5 7.6
Carbone dioxide (mmol/l) 23.0−29.0 22.2
Intact parathyroid hormone (pg/ml) 15−65 103
Urinalysis
Screening dipstick test
White cells (per μl) 0-10 0
Nitrites neg. neg.
pH 5.0−6.0 5.5
Protein (mg/dl) neg. >300
Glucose (mg/dl) neg. 500
Ketones (mg/dl) neg. neg.
Urobilinogen (mg/dl) <1.0 0.2
Bilirubin neg. neg.
Blood (per μl) 0-5 appr. 25
Specific weight (g/l) 1005−1030 1025
Sediment
White cells (per high-power field) <10 1-3
Red cells (per high-power field) <2 1-3
Epithelial cells (per high-power field) - +
Hyaline casts (per low-power field) - +
Granulated casts (per low-power field) - +
Cellular casts (per low-power field) - +
Table 1 Laboratory data at presentation (Continued)
Urinary chemistry
BUN (urine) (mg/dl) 700.0−1213.0 492
Creatinine (urine) (mg/dl) 30.0−220.0 79.2
Protein (urine) (mg/dl) <15.0 296
Protein/creatinine ratio (mg/g) <100.0 3,740
Albumin (urine) (mg/dl) <2.0 210
Albumin/creatinine ratio (mg/g)) <20.0 2,645
α1−Microglobulin (urine) (mg/l) <12.0 106
α1−Microglobulin/creatinine (mg/g) <14.0 133
Immunology
Monoclonal immunoglobulins negative
Complement C3 (mg/dl) 90.0−180.0 115
Complement C4 (mg/dl) 10.0−40.0 31.7
Antinuclear antibodies (ANA) 1:120
Antineutrophil cytoplasmic antibodies (ANCA) negative
Anti basal membrane antibodies (ELISA)
(IU/ml)
<20.000 <20.0
Values outside the reference range are shown in bold print.
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atinine levels slowly rose to a maximum of 4.3 mg/dl
(eGFR 10.3 ml/min/1.73 m2) within 2 months. Currently,
the patient is treated in our outpatient clinic for end
stage renal disease (ESRD), and options for fistulas are
being evaluated in preparation for hemodialysis.Discussion
Apart from genetic forms of hyperoxaluria (PH1 to 3),
hyperoxaluria and hyperoxalemia can occur upon
increased dietary intake of foods that have a high oxalate
content such as cocoa (mean oxalate content 700 mg/
100 g fresh weight (FW) [7]), rhubarb (raw 805 mg/
100 g FW, stewed 460 mg/100 g FW [7]), spinach
(970 mg/100 g FW [7]), black teas (1150 mg/100 g
FW [7]), beet leaves (610 mg/100 g FW [7]), and star
fruit (263 mg/100 g FW [8]). Interestingly, there is
some data that herbal medicines containing rhubarb
might actually improve renal function, including the
reduction of proteiuria, slowing progression of chronic
kidney disease or ameliorating dyslipidemia [9]. Anti-
inflammatory and anti-fibrotic effects are discussed. It has
not been reported that regular consumption of these pre-
parations caused secondary hyperoxaluria and renal fail-
ure. Since ascorbic acid can be metabolized to oxalate,
high intake of vitamin C may also cause hyperoxaluria [5].
Several cases of acute deterioration of renal func-
tion secondary to oxalate crystal deposition have been
described with a majority comprising malabsorption syn-
dromes such as pancreatitis or gastric by-pass as well as
Figure 1 (A) Oxalate crystals (arrows) within the renal tubular
lumen in a hematoxylin eosin-stained section (original
magnification x200) and (B) under polarisation light
microscopy (original magnification x100). Adjacent glomeruli
show mild diabetic mesangial sclerosis.
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reports illustrated a deteriorated renal function after
consumption of star fruit [13] or peanuts [14], both of
which containing high amounts of oxalate. There are
only few reports that described oral rhubarb ingestion
as a cause of oxalate-induced kidney injury, most of
which occurred in children [15].
Here, we report an adult patient with initially unex-
plained acute renal failure. Surprisingly, her kidney biopsy
revealed deposition of disseminated crystals within the
tubular lumen suggestive for calcium oxalate deposition.Table 2 24 hour urine analysis
Variable Referance range Result
Oxalate (mmol/1,73 m2/d) <0.5 0.39
Glycolate (mmol/1,73 m2/d) <0.5 0.34
Citrate (mmol/d) 0.3 – 7.4 2.25
Calcium (mg/d) <250 176As no other causes of the patient’s acute renal failure
could be elucidated, she was carefully questioned regard-
ing oxalate intake. She reported an extensive consumption
of rhubarb, i.e. 500 mg fresh weight of plant per day for
the least 4 weeks. This resulted in an uptake of approxi-
mately 2.3 g oxalate per day [7]. In a study by Holmes
et al. a dose of approximately 1 g oxalate was given to
healthy subjects without evidence of acute renal injury
or oxidative stress [16]. However, the minimal dose of
oxalate causing death in adults is 4–5 g [15]. These
cases often show typical birefringent oxalate deposition
in the tubular lumen and in tubular epithelial cells [15].
To our knowledge, there is no data defining a threshold
for oxalate intake that would result in nephropathy. Our
patient had a known history of diabetes mellitus type 1
and chronic kidney disease stage I with microalbumi-
nuria, but without a previous impairment of excretory
renal function. We assume that in this patient a mildly
injured diabetic kidney suffered a“second hit”by oxalate
crystal deposition within tubuli leading to acute renal
failure.
In addition, a prerenal component may have contrib-
uted to the acute kidney failure due to the initial epi-
sode of nausea and vomiting with a prolonged state of
hypoglycemia. Importantly, there is evidence that reduc-
tions of GFR facilitate precipitation of calcium-oxalate
crystals [17]. However, renal biopsy revealed no changes
suggestive for prerenal or ischemic renal failure, but
showed prominent oxalate crystal deposition. Thus, it is
unlikely that dehydration was the primary cause that lead
to a prerenal form of renal failure in this patient. Instead,
the patient’s initial episodes of nausea and vomiting
could have been symptoms of her acute renal failure.
There are few data on long term-outcomes of patients
with secondary oxalate nephropathy. A retrospective
analysis of twelve French patients with acute oxalate
nephropathy reported ESRD in three of 12 patients
after a median follow-up of 7 months [10]. Therapeutic
approaches are limited and comprise increased fluid
intake, probiotics [18], low-oxalate diet [19] and hemo-
dialysis or peritoneal dialysis for ESRD [20]. There is
inconclusive data considering probiotic therapy. Of note,
Oxalobacter formigenes colonizes the human intestine
and relies on the metabolism of oxalate [3]. Several
reports and small studies describe a potential benefit of
Oxalobacter treatment on lowering both plasma and
urinary oxalate levels [18,21]. Even though these data
appear promising, there is still uncertainty about its
efficacy and correct dosing, and larger studies are
needed [22].
Conclusion
We report a rare case of acute secondary oxalate nephro-
pathy, likely due to excessive ingestion of rhubarb in an
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to crystal-induced acute renal failure. Thus, we recom-
mend careful questioning of dietary habits or intoxications
when reasons for acute renal failure are investigated.
Moreover, patients with chronic renal functional impair-
ment may be advised to avoid oral intake of excessive
amounts of oxalate-containing foods such as rhubarb or
spinach.
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